Brokerages Expect NextGen Healthcare, Inc. (NASDAQ:NXGN) to Post $0.20 EPS

Wall Street analysts expect NextGen Healthcare, Inc. (NASDAQ:NXGNGet Rating) to announce earnings per share (EPS) of $0.20 for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for NextGen Healthcare’s earnings, with estimates ranging from $0.19 to $0.21. NextGen Healthcare posted earnings of $0.21 per share in the same quarter last year, which suggests a negative year-over-year growth rate of 4.8%. The business is scheduled to announce its next quarterly earnings results after the market closes on Monday, January 1st.

According to Zacks, analysts expect that NextGen Healthcare will report full year earnings of $0.99 per share for the current year, with EPS estimates ranging from $0.98 to $1.00. For the next fiscal year, analysts expect that the company will post earnings of $0.99 per share, with EPS estimates ranging from $0.98 to $1.00. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that that provide coverage for NextGen Healthcare.

A number of equities research analysts have recently issued reports on NXGN shares. StockNews.com started coverage on NextGen Healthcare in a research report on Thursday, March 31st. They set a “strong-buy” rating on the stock. Zacks Investment Research lowered shares of NextGen Healthcare from a “hold” rating to a “sell” rating and set a $21.00 price objective for the company. in a research note on Thursday, May 5th. Piper Sandler lifted their target price on shares of NextGen Healthcare from $23.00 to $24.00 in a research report on Wednesday, January 26th. Finally, Guggenheim upgraded shares of NextGen Healthcare from a “neutral” rating to a “buy” rating and set a $26.00 price target for the company in a research report on Friday. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $22.17.

Shares of NASDAQ:NXGN opened at $18.98 on Tuesday. The company has a market capitalization of $1.27 billion, a PE ratio of 1,899.90, a price-to-earnings-growth ratio of 5.57 and a beta of 1.17. The stock has a fifty day moving average of $20.27 and a 200-day moving average of $18.53. NextGen Healthcare has a one year low of $13.64 and a one year high of $21.87.

In other news, CAO David Ahmadzai sold 6,250 shares of NextGen Healthcare stock in a transaction dated Tuesday, March 15th. The stock was sold at an average price of $19.55, for a total transaction of $122,187.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Donna Cullen Greene sold 63,625 shares of the stock in a transaction that occurred on Thursday, March 3rd. The stock was sold at an average price of $20.05, for a total value of $1,275,681.25. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 144,551 shares of company stock valued at $2,896,091. 18.70% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently made changes to their positions in the company. Louisiana State Employees Retirement System boosted its stake in shares of NextGen Healthcare by 2.2% during the 4th quarter. Louisiana State Employees Retirement System now owns 27,800 shares of the company’s stock worth $495,000 after acquiring an additional 600 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in NextGen Healthcare during the third quarter valued at approximately $250,000. Meritage Portfolio Management bought a new position in shares of NextGen Healthcare in the fourth quarter valued at approximately $301,000. Jackson Creek Investment Advisors LLC acquired a new stake in shares of NextGen Healthcare in the fourth quarter worth $1,186,000. Finally, Royce & Associates LP boosted its holdings in shares of NextGen Healthcare by 20.8% during the 4th quarter. Royce & Associates LP now owns 51,923 shares of the company’s stock worth $924,000 after buying an additional 8,940 shares during the period. Institutional investors own 71.15% of the company’s stock.

NextGen Healthcare Company Profile (Get Rating)

NextGen Healthcare, Inc provides software and services for ambulatory healthcare services in the United States. The company offers patient engagement solutions, comprising of NextGen PxP Portal, NextGen Patient Self Scheduling, NextGen Pay, and NextGen Virtual Visits; clinical care solutions, including NextGen Enterprise HER, NextGen Mobile, NextGen Office, NextGen Behavioral Health Suite, NextGen Orthopedic Suite, and QSIDental Web and QSIDental PM; and financial management solutions, such as NextGen Enterprise PM and NextGen Clearinghouse Solutions.

Read More

Get a free copy of the Zacks research report on NextGen Healthcare (NXGN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for NextGen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.